ArticleRSC advances2026
Novel pH-responsive pectin-based hybrid smart hydrogels for in vitro drug release and in vivo wound healing applications.
Article in RSC advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Vat Photopolymerization-Fabricated Theranostic Hydrogels for Smart Wound Management.Gels (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Despite their exceptional biocompatibility and non-toxicity, pectin-based hydrogels suffer from poor mechanical strength, water sensitivity and high instability, which limit their utilization in the biomedical sector. Therefore, main objective behind this study was to develop integrated pectin-based hydrogel system to improve mechanical and structural properties of hydrogels for biomedical applications. Multifunctional hydrogels were formulated to integrate the gel-forming capabilities and biocompatibility of polyvinyl alcohol (PVA) and pectin, with the crosslinking and structural reinforcement of 3-aminopropyltriethoxysilane (APTES), and the antimicrobial and drug-loading capabilities of graphene oxide (GO) fillers. Using varied GO concentrations, pectin/PVA/APTES/GO hydrogel series PPG (-2.5, -5, -7.5, and -10) was synthesized, and samples' structural integrity, amorphous nature, porous morphology, and thermal stability were characterized. The hydrogels demonstrated high cell viability, biodegradation, and antibacterial activity, and their swelling in distilled water (DW) reached a maximum value of 3300% in 120 min. The greatest degree of swelling was observed at pH 8 in both buffered and non-buffered solutions. Following the Higuchi, zero-order, and Korsmeyer-Peppas models for controlled release kinetics, 91.44% of levofloxacin (LVX) was released from the drug-loaded hydrogel (DPPG) within 3.5 hours in a PBS (pH 7.4) solution. Furthermore,
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.